
Other17 Jun 2026, 01:33 pm
Vivimed Labs Invites Expressions of Interest for Resolution
AI Summary
Vivimed Labs Limited has issued a Form G inviting expressions of interest for its corporate insolvency resolution process. The company operates in the business of manufacturing pharma dosage forms across multiple locations in India, including Hyderabad, Haridwar, Kashipur, and Bidar. The filing provides details on installed capacities, revenue from operations for FY24-25 and FY23-24, and the number of employees. The last date for receipt of expressions of interest is June 29, 2026, with subsequent dates set for the provisional and final lists of prospective resolution applicants, and the submission of resolution plans.
Key Highlights
- Vivimed Labs initiates Corporate Insolvency Resolution Process (CIRP).
- Invites Expressions of Interest for resolution applicants.
- Manufacturing facilities located in Hyderabad, Haridwar, Kashipur, and Bidar.
- Revenue from operations reported for FY24-25 and FY23-24.
- Key dates for the resolution process are outlined.
Price Impact
More from VIVIMEDLAB